VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,482,642 Value ($000) $16,650 Avg Close — Range —
Q1 2025
Shares 1,413,118 Value ($000) $6,458 Avg Close — Range —
Q4 2024
Shares 741,179 Value ($000) $4,180 Avg Close — Range —
Q3 2024
Shares 1,048,066 Value ($000) $5,073 Avg Close — Range —
Q2 2024
Shares 1,288,249 Value ($000) $6,287 Avg Close — Range —
Q1 2024
Shares 830,870 Value ($000) $11,034 Avg Close — Range —
Q4 2023
Shares 473,616 Value ($000) $6,602 Avg Close — Range —
Q3 2023
Shares 205,537 Value ($000) $2,725 Avg Close — Range —
Q2 2023
Shares 267,078 Value ($000) $5,008 Avg Close — Range —
Q1 2023
Shares 262,943 Value ($000) $3,792 Avg Close — Range —
Q4 2022
Shares 394,234 Value ($000) $7,628 Avg Close — Range —
Q3 2022
Shares 303,353 Value ($000) $10 Avg Close — Range —
Q2 2022
Shares 74,759 Value ($000) $1 Avg Close — Range —
Q1 2022
Shares 106,368 Value ($000) $2,427 Avg Close — Range —
Q4 2021
Shares 52,400 Value ($000) $1,932 Avg Close — Range —
Q3 2021
Shares 42,154 Value ($000) $1,981 Avg Close — Range —
Q2 2021
Shares 118,513 Value ($000) $7,140 Avg Close — Range —